This study reevaluates the clinical ability to accurately identify jaundice in neonates. Three hundred seventy-one term infants were clinically asseseed forjaundice, before discharge home on day 2 to 3 of life. Bilirubin levels obtained at the same time were significantly higher in the newborns clinically diagnosed as being jaundiced. Our neonatologists were able to diagnose jaundice at clinically low levels, and not to misdiagnose significant hyperbilirubinemia in the majority of the infants. The trained human eye can still discriminate between the jaundiced and nonjaundiced newborn, and clinical impression of jaundice remains a reliable primary screening tool for significant neonatal hyperbilirubinemia.
Get full access to this article
View all access options for this article.
References
1.
1. Practice parameter: management of hyperbilirubinemia in the healthy term newborn. American Academy of Pediatrics. Provisional Committee for Quality Improvement and Subcommittee on Hyperbilirubinemia. Pediatrics. 1994;94(4 Pt 1):558-565.
2.
2. Maisels MJ, Gifford K, Antle CE, Leib GR.Jaundice in the healthy newborninfant: a new approach to an old problem. Pediatrics. 1988;81(4):505-511.
3.
3. Maisels MJ.Jaundice. In: Avery GB, Fletcher MA, Mac Donald MG, eds. Neonatology, Pathophysiology and Managment of the Newborn. 5th ed.New York: Lippincott, Williams & Wilkins; 1999:765-819.
4.
4. Kivlahan C, James EJ.The natural history of neonatal jaundice. Pediatrics. 1984;74(3):364-370.
5.
5. Knudsen A, Brodersen R.Skin colour and bilirubin in neonates. Arch Dis Child. 1989;64(4):605-609.
6.
6. Tayaba R, Gribetz D, Gribetz I, Holzman IR.Noninvasive estimation of serum bilirubin. Pediatrics. 1998;102(3):E28-E28.
7.
7. Madlon-Kay DJ.Recognition of the presence and severity of newborn jaundice by parents, nurses, physicians, and icterometer. Pediatrics. 1997;100(3):E3-E3.
8.
8. Moyer VA, Ahn C, Sneed S.Accuracy of clinical judgment in neonatal jaundice. Arch Pediatr Adolesc Med. 2000;154(4):391-394.
9.
9. Penn AA, Enzmann DR, Hahn JS, Stevenson DK.Kernicterus in a full term infant. Pediatrics. 1994;93(6 Pt 1):1003-1006.
10.
10. Maisels MJ, Newman TB.Kernicterus in otherwise healthy, breast-fed term newborns. Pediatrics. 1995;96(4 Pt 1):730-733.
11.
11. Newman TB, Maisels MJ.Less aggressive treatment of neonatal jaundice and reports of kemicterus: lessons about practice guidelines. Pediatrics. 2000;105(I Pt 3):242-245.
12.
12. Kaplan M, Hammerman C.Glucose-6phosphate dehydrogenase-deficient neonates: a potential cause for concern in North America. Pediatrics. 2000;106(6):1478-1479.
13.
13. van der Laan EA, Tolboom Jj. [Neonatal jaundice, a diagnostic approach]. Tijdschr Kindergeneeskd. 1993;61(4):158-164.
14.
14. Maisels MJ.Clinical rounds in the well-baby nursery: treating jaundiced newborns. Pediatr Ann. 1995;24(10):547-552.
15.
15. Newman TB, Maisels MJ.Evaluation and treatment ofjaundice in the term newborn: a kinder, gentler approach. Pediatrics. 1992;89(5 Pt 1):809-818.
16.
16. Brown AK, Seidman DS, Stevenson DK.Jaundice in healthy, term neonates: do we need new action levels or new approaches?Pediatrics. 1992;89(5 Pt 1):827-829.
17.
17. Cashore WJ.Hyperbilirubinemia: should we adopt a new standard of care?Pediatrics. 1992;89(5 Pt 1):824-826.
18.
18. Gartner LM.Management ofjaundice in the well baby. Pediatrics. 1992;89(5 Pt 1):826-827.
19.
19. Bhutani VK, Johnson L, Sivieri EM.Predictive ability of a predischarge hour specific serum bilirubin for subsequent significant hyperbilirubinernia in healthy term and nearterm newborns. Pediatrics. 1999;103(l):6-14.
20.
20. Cashore WJ.Neonatal hyperbilirubinemia. In: Oski FA, ed. Principles and Practice of Pediatrics. Philadelphia: Lippincott; 1990:399-408.
21.
21. Maisels MJ.Jaundice. In: Avery GB, ed. Neonatology, Pathophysiology and Managment of the Newborn. 4th ed.New York: Lippincott, Williams & Wilkins;1994:630-725.
22.
22. Kramer LI.Advancement of dermal icterus in the jaundiced newborn. Am J Dis Child. 1969;118(3):454-458.
23.
23. Ebbesen F.The relationship between the cephalo-pedal progress of clinical icterus and the serum bilirubin concentration in newborn infants without blood type sensitization. Acta Obstet Gynecol Scand. 1975;54(4):329-332.
24.
24. Manzar S.Cephalo-caudal progression ofjaundice: a reliable, noninvasive clinical method to assess the degree of neonatal hyperbilirubinemia. J Trop Pediatr. 1999;45(5):312-313.
25.
25. Knudsen A.The cephalocaudal progression of jaundice in newborns in relation to the transfer of bilirubin from plasma to skin. Early Hum Dev. 1990;22(1):23-28.
26.
26. Hegyi T, Hiatt IM, Gertner I, Indyk L.Transcutaneous bilirubinometry. The cephalocaudal progression of dermal icterus. Am J Dis Child. 1981;135(6):547-549.
27.
27. Hegyi T, Hiatt IM, Indyk L.Transcutaneous bilirubinometry. I. Correlations in term infants. J Pediatr. 1981;98(3):454-457.
28.
28. Knudsen A.The influence of the reserve albumin concentration and p H on the cephalocaudal progression of jaundice in newborns. Early Hum Dev. 1991;25(l):37-41.
29.
29. Schumacher RE, Thornbery JM, Gutcher GR.Transcutaneous bilirubinometry: a comparison of old and new methods. Pediatrics. 1985;76(1):10-14.
30.
30. Schumacher RE.Noninvasive measurements of bilirubin in the newborn. Clin Perinatol. 1990;17(2):417-435.
31.
31. Maisels MJ, Kring E.Transcutaneous bilirubinometry decreases the need for serum bilirubin measurements and saves money. Pediatrics. 1997;99(4):599-601.
